Avalo Therapeutics, Inc. (AVTX)
12.87
+0.01
(+0.08%)
USD |
NASDAQ |
Apr 29, 14:20
Avalo Therapeutics Research and Development Expense (TTM) : 50.08M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| AbbVie, Inc. | 9.096B |
| Relmada Therapeutics, Inc. | 26.88M |
| Theravance Biopharma, Inc. | 35.79M |
| Corcept Therapeutics, Inc. | 254.91M |